Literature DB >> 3034086

Loss of granule myeloperoxidase during in vitro culture of human monocytes correlates with decay in antiprotozoa activity.

R M Locksley, C S Nelson, J E Fankhauser, S J Klebanoff.   

Abstract

Human monocytes maintained in culture lose microbicidal activity against intracellular protozoa which has been correlated with attenuation of the respiratory burst. The granule enzyme myeloperoxidase, which can markedly amplify hydrogen peroxide-dependent antimicrobial activity, is also lost in vitro. Adherent monocytes were examined immediately, 3 and 10-14 days following explantation, for the magnitude of the stimulated respiratory burst and for cellular myeloperoxidase. Fresh cells generated 254 +/- 38 nmol O2-/mg protein as compared to a peak of 782 +/- 45 nmol O2-/mg at 3 days and less than 100 nmol O2-/mg after 10-14 days. The myeloperoxidase content of the cells also decreased; over 85% was lost after 3 days. Fresh monocytes killed over 90% of ingested Toxoplasma gondii or Leishmania major. In contrast, 10-14 day explanted monocytes killed only 12% of ingested Toxoplasma and 33% of Leishmania, and surviving organisms replicated readily. The 3-day monocytes were significantly less able to kill protozoa than were fresh cells despite their nearly 3-fold greater generation of O2-. If peroxidase was reintroduced into 3-day monocytes by coating organisms with eosinophil peroxidase prior to phagocytosis, their antiprotozoa activity was nearly restored to that of freshly explanted cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034086     DOI: 10.4269/ajtmh.1987.36.541

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Differential infectivity and division of Toxoplasma gondii in human peripheral blood leukocytes.

Authors:  J Y Channon; R M Seguin; L H Kasper
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

2.  DNA Hypermethylation and a Specific Methylation Spectrum on the X Chromosome in Turner Syndrome as Determined by Nanopore Sequencing.

Authors:  Xin Fan; Beibei Zhang; Lijun Fan; Jiajia Chen; Chang Su; Bingyan Cao; Liya Wei; Miao Qin; Chunxiu Gong
Journal:  J Pers Med       Date:  2022-05-26

3.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Bactericidal activity against Pseudomonas aeruginosa is acquired by cultured human monocyte-derived macrophages after uptake of myeloperoxidase.

Authors:  M Mathy-Hartert; G Deby-Dupont; P Melin; M Lamy; C Deby
Journal:  Experientia       Date:  1996-02-15

5.  Neutrophils and macrophages: the main partners of phagocyte cell systems.

Authors:  Manuel T Silva; Margarida Correia-Neves
Journal:  Front Immunol       Date:  2012-07-04       Impact factor: 7.561

6.  Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites.

Authors:  Fitsumbrhan Tajebe; Mulusew Getahun; Emebet Adem; Asrat Hailu; Mulualem Lemma; Helina Fikre; John Raynes; Aschalew Tamiru; Zemenay Mulugeta; Ermias Diro; Frederic Toulza; Ziv Shkedy; Tadesse Ayele; Manuel Modolell; Markus Munder; Ingrid Müller; Yegnasew Takele; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2017-07-21

7.  Analysis of the nonfunctional respiratory burst in murine Kupffer cells.

Authors:  A Ding; C Nathan
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

8.  Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity.

Authors:  E C Yong; E Y Chi; W R Henderson
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

9.  Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions.

Authors:  Endalew Yizengaw; Mulusew Getahun; Fitsumbrhan Tajebe; Edward Cruz Cervera; Emebet Adem; Getnet Mesfin; Asrat Hailu; Gert Van der Auwera; Vanessa Yardley; Mulualem Lemma; Ziv Skhedy; Ermias Diro; Arega Yeshanew; Roma Melkamu; Bewketu Mengesha; Manuel Modolell; Markus Munder; Ingrid Müller; Yegnasew Takele; Pascale Kropf
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.